Insider · CIK 0001527064

Borland Scott

Reports to the SEC for 1 company · MOUNTAIN VIEW, CA

sec.gov

Transactions

Companies

Filings

CIK

0001527064

Forms 4 and 5

Insider transactions

41 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2013-03-01	MAP Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer	SVP, Neurology Franchise	DDisposition to Issuer	−4,375 sh	—	—	0
2013-03-01	MAP Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer	SVP, Neurology Franchise	DDisposition to Issuer	−1,800 sh	—	—	0
2013-03-01	MAP Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer	SVP, Neurology Franchise	DDisposition to Issuer	−3,000 sh	—	—	0
2013-03-01	MAP Pharmaceuticals, Inc.Restricted Stock Unit (RSU)D Disposition to Issuer	SVP, Neurology Franchise	DDisposition to Issuer	−750 sh	—	—	0
2013-03-01	MAP Pharmaceuticals, Inc.Restricted Stock Unit (RSU)D Disposition to Issuer	SVP, Neurology Franchise	DDisposition to Issuer	−300 sh	—	—	0
2013-03-01	MAP Pharmaceuticals, Inc.Restricted Stock Unit (RSU)D Disposition to Issuer	SVP, Neurology Franchise	DDisposition to Issuer	−8,250 sh	—	—	0
2013-03-01	MAP Pharmaceuticals, Inc.Restricted Stock Unit (RSU)D Disposition to Issuer	SVP, Neurology Franchise	DDisposition to Issuer	−3,375 sh	—	—	0
2013-03-01	MAP Pharmaceuticals, Inc.Restricted Stock Unit (RSU)D Disposition to Issuer	SVP, Neurology Franchise	DDisposition to Issuer	−3,500 sh	—	—	0
2013-03-01	MAP Pharmaceuticals, Inc.U Disposition from Tender	SVP, Neurology Franchise	UDisposition from Tender	−13K sh	$25.00	−$324K	0
2013-03-01	MAP Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer	SVP, Neurology Franchise	DDisposition to Issuer	−1,648 sh	—	—	0
2013-03-01	MAP Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer	SVP, Neurology Franchise	DDisposition to Issuer	−1,589 sh	—	—	0
2013-03-01	MAP Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer	SVP, Neurology Franchise	DDisposition to Issuer	−10K sh	—	—	0
2013-03-01	MAP Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer	SVP, Neurology Franchise	DDisposition to Issuer	−51.5K sh	—	—	0
2013-03-01	MAP Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer	SVP, Neurology Franchise	DDisposition to Issuer	−35K sh	—	—	0
2013-03-01	MAP Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer	SVP, Neurology Franchise	DDisposition to Issuer	−21K sh	—	—	0
2013-03-01	MAP Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer	SVP, Neurology Franchise	DDisposition to Issuer	−13.8K sh	—	—	0
2013-03-01	MAP Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer	SVP, Neurology Franchise	DDisposition to Issuer	−32.5K sh	—	—	0
2013-03-01	MAP Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer	SVP, Neurology Franchise	DDisposition to Issuer	−248 sh	—	—	0
2013-03-01	MAP Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer	SVP, Neurology Franchise	DDisposition to Issuer	−4,237 sh	—	—	0
2013-03-01	MAP Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer	SVP, Neurology Franchise	DDisposition to Issuer	−2,500 sh	—	—	0
2013-03-01	MAP Pharmaceuticals, Inc.Stock Option (Right to Buy)D Disposition to Issuer	SVP, Neurology Franchise	DDisposition to Issuer	−5,000 sh	—	—	0
2013-01-26	MAP Pharmaceuticals, Inc.Restricted Stock Unit (RSU)M Exercise/Conversion	SVP, Neurology Franchise	MExercise/Conversion	−1,900 sh	—	—	3,800
2013-01-26	MAP Pharmaceuticals, Inc.M Exercise/Conversion	SVP, Neurology Franchise	MExercise/Conversion	+1,900 sh	—	—	13,058
2013-01-26	MAP Pharmaceuticals, Inc.S Sale	SVP, Neurology Franchise	SSale	−764 sh	$24.75	−$18.9K	12,294
2013-01-25	MAP Pharmaceuticals, Inc.Restricted Stock Unit (RSU)M Exercise/Conversion	SVP, Neurology Franchise	MExercise/Conversion	−3,000 sh	—	—	9,000
2013-01-25	MAP Pharmaceuticals, Inc.F Tax Payment	SVP, Neurology Franchise	FTax Payment	−1,317 sh	$24.75	−$32.6K	11,158
2013-01-25	MAP Pharmaceuticals, Inc.M Exercise/Conversion	SVP, Neurology Franchise	MExercise/Conversion	+3,000 sh	—	—	12,475
2012-11-20	MAP Pharmaceuticals, Inc.J Other	SVP, Neurology Franchise	JOther	+1,158 sh	$9.89	+$11.5K	9,475
2012-06-07	MAP Pharmaceuticals, Inc.M Exercise/Conversion	SVP, Neurology Franchise	MExercise/Conversion	+1,125 sh	—	—	7,592
2012-06-07	MAP Pharmaceuticals, Inc.F Tax Payment	SVP, Neurology Franchise	FTax Payment	−414 sh	$12.01	−$4,972.14	7,178
2012-06-07	MAP Pharmaceuticals, Inc.Restricted Stock UnitM Exercise/Conversion	SVP, Neurology Franchise	MExercise/Conversion	−1,125 sh	—	—	3,375
2012-05-20	MAP Pharmaceuticals, Inc.J Other	SVP, Neurology Franchise	JOther	+1,139 sh	$9.81	+$11.2K	8,317
2012-01-26	MAP Pharmaceuticals, Inc.F Tax Payment	SVP, Neurology Franchise	FTax Payment	−796 sh	$13.84	−$11K	6,467
2012-01-26	MAP Pharmaceuticals, Inc.Restricted Stock Unit (RSU)M Exercise/Conversion	SVP, Neurology Franchise	MExercise/Conversion	−1,900 sh	—	—	5,700
2012-01-26	MAP Pharmaceuticals, Inc.M Exercise/Conversion	SVP, Neurology Franchise	MExercise/Conversion	+1,900 sh	—	—	7,263
2012-01-25	MAP Pharmaceuticals, Inc.Stock Option (Right to Buy)A Award	SVP, Neurology Franchise	AAward	+35.5K sh	—	—	35,500
2012-01-25	MAP Pharmaceuticals, Inc.Restricted Stock Unit (RSU)A Award	SVP, Neurology Franchise	AAward	+12K sh	—	—	12,000
2011-11-20	MAP Pharmaceuticals, Inc.J Other	SVP, Neurology Franchise	JOther	+896 sh	$11.54	+$10.3K	5,363
2011-08-04	MAP Pharmaceuticals, Inc.Restricted Stock UnitM Exercise/Conversion	SVP, Neurology Franchise	MExercise/Conversion	−5,000 sh	—	—	3,165
2011-08-04	MAP Pharmaceuticals, Inc.F Tax Payment	SVP, Neurology Franchise	FTax Payment	−1,835 sh	$13.43	−$24.6K	4,467
2011-08-04	MAP Pharmaceuticals, Inc.M Exercise/Conversion	SVP, Neurology Franchise	MExercise/Conversion	+5,000 sh	—	—	6,302

Recent filings

Accepted (ET)
Mar 44
Borland Scott0001181431-13-014237
SEC(opens sec.gov)

Companies

MAP Pharmaceuticals, Inc.SVP, Neurology Franchise

Address

2400 BAYSHORE PARKWAY SUITE 200

MOUNTAIN VIEW, CA, 94043